Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 3193: Treatment of high Trop-2-expressing triple-negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51

Cancer Res (2017) 77 (13_Supplement): 3193.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Jenny Furlanetto
  • Frederik Marmé
  • Sibylle Loibl
Future Oncology (2022) 18 (28): 3199.
  • Yahiya Y. Syed
Drugs (2020) 80 (10): 1019.
  • David M. Goldenberg
  • Robert M. Sharkey
Expert Opinion on Biological Therapy (2020) 20 (8): 871.
  • David M. Goldenberg
  • Rhona Stein
  • Robert M. Sharkey
Oncotarget (2018) 9 (48): 28989.
Close Modal

or Create an Account

Close Modal
Close Modal